Medicare Enrolled

Dr. Christopher Cochrane, D.O.

Physical Medicine & Rehabilitation · Tacoma, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
9040 JACKSON AVE, Tacoma, WA 98431
2539682252
In practice since 2007 (19 years)
NPI: 1306044334 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cochrane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cochrane? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cochrane

Dr. Christopher Cochrane is a physical medicine & rehabilitation specialist in Tacoma, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cochrane performed 1,390 Medicare services across 634 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cochrane received a total of $2,976 from 27 pharmaceutical and/or device companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physical medicine & rehabilitation. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cochrane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 21% volume in WA $2,976 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,390
Medicare services
Top 21% in WA for physical medicine & rehabilitation
634
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~73 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging, lower concentration 300 $0 $1
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
241 $62 $195
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
160 $0 $1
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
149 $77 $269
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
80 $76 $324
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
68 $55 $205
Injection, methylprednisolone acetate, 40 mg 46 $6 $12
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
44 $41 $377
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
31 $9 $23
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
30 $95 $654
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
29 $44 $217
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
29 $193 $601
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
27 $98 $273
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
24 $160 $764
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $78 $252
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
21 $126 $690
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
20 $151 $542
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
18 $321 $1,293
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
18 $180 $647
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
16 $169 $792
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
15 $187 $734
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,976
Total received (2020-2024)
Avg $595/year across 5 years
Top 13% in WA for physical medicine & rehabilitation
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
108
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,976 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$635
2023
$526
2022
$937
2021
$363
2020
$516

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$367
ABBVIE INC.
$77
SI-BONE, INC.
$71
Merz Pharmaceuticals, LLC
$30
Virtus Pharmaceuticals LLC
$27
Saluda Medical Americas, Inc.
$22
Azurity Pharmaceuticals, Inc.
$22
PFIZER INC.
$19
Top 3 companies account for 81.1% of 2024 payments
All-time payments by company (2020-2024) ›
Medtronic, Inc.
$1,126
Merz Pharmaceuticals, LLC
$324
Medtronic USA, Inc.
$302
ABBVIE INC.
$123
PFIZER INC.
$116
Nevro Corp.
$115
Mentor Worldwide LLC
$101
Kowa Pharmaceuticals America, Inc.
$89
AbbVie Inc.
$78
SI-BONE, INC.
$71
Orexo US, Inc.
$67
Azurity Pharmaceuticals, Inc.
$58
Biohaven Pharmaceutical Holding Company Ltd.
$50
Boston Scientific Corporation
$44
Allergan, Inc.
$38
Ipsen Biopharmaceuticals, Inc
$38
Otto Bock HealthCare LP
$31
Averitas Pharma Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$28
Virtus Pharmaceuticals LLC
$27
Saluda Medical Americas, Inc.
$22
Alexion Pharmaceuticals, Inc.
$22
GRT US Holding, Inc.
$19
Biohaven Pharmaceuticals, Inc.
$19
Amgen Inc.
$16
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$15
Stratus Medical, LLC
$11
Top 3 companies account for 58.9% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · Accurian · BELBUCA · BOTOX · DYSPORT · Evoke · FLECTOR · GENERAL - PAIN MANAGEMENT · HORIZANT · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · LEVORPHANOL TARTRATE · LYRICA · MENTOR MemoryShape Breast Implant · NImbus · NURTEC ODT · Omnia · QULIPTA · QUTENZA · Qutenza · SEGLENTIS · SPECTRA WAVEWRITER · SYNCHROMEDII · Seglentis · Senza Spinal Cord Stimulation System · Soliris · UBRELVY · Xeomin · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a physical medicine & rehabilitation specialist in Tacoma?
Compare physical medicine & rehabilitations in the Tacoma area by procedure volume, costs, and industry payment transparency.
Browse physical medicine & rehabilitations nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cochrane is a clinical cardiology specialist, with above-average Medicare volume (top 21% in WA), with low-engagement industry engagement in the top 13% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cochrane experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Cochrane performed 300 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cochrane receive payments from pharmaceutical companies?
Yes. Dr. Cochrane received a total of $2,976 from 27 companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cochrane's costs compare to other physical medicine & rehabilitations in Tacoma?
Dr. Cochrane's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cochrane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →